Projects funded by the NCN
Epigenetic Reprograming and All-trans-Retinoic Acid in Therapy of Myelodysplastic Syndromes
2021/41/B/NZ5/04397
Keywords:
Retinoic Acid MDS Epigenetic Therapy LSD1 ASXL1
Descriptors:
- NZ5_7: Human disease treatment
- NZ2_1: Molecular genetics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Genetyki i Biotechnologii Zwierząt Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 2 657 160 PLN
Project start date (Y-m-d): 2022-08-01
Project end date (Y-m-d): 2025-07-31
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.